Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28831350 | 0.74 | FDPS (0.37) | FDPS | |
| SCHEMBL1393689 | 0.71 | CA12 (0.32) | — | |
| SCHEMBL20366737 | 0.71 | — | — | |
| SCHEMBL28831316 | 0.70 | DNM1 (0.42) | FDPS | |
| SCHEMBL4009927 | 0.70 | — | — | |
| SCHEMBL5359485 | 0.67 | FDPS (0.32) | FDPS | |
| SCHEMBL4268210 | 0.67 | — | — | |
| SCHEMBL22388911 | 0.65 | — | — | |
| SCHEMBL20366416 | 0.63 | — | — | |
| SCHEMBL28899407 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331687-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | CELANESE INT CORP (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230322696-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | CELANESE INT CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230322697-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | CELANESE INT CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230322698-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | CELANESE INT CORP (US) | 2023-10-12 | — | — | US | disclosed |
| EP-4248762-A2 | PROCESS FOR PRODUCING ACESULFAME POTASSIUM | Celanese Sales Germany GmbH (DE) | 2023-09-27 | — | — | EP | disclosed |
| EP-3210978-B1 | PROCESS FOR PRODUCING ACESULFAME POTASSIUM | CELANESE SALES GERMANY GMBH (DE) | 2023-09-06 | — | — | EP | disclosed |
| US-11731948-B2 | Acesulfame potassium compositions and processes for producing same | CELANESE INTERNATIONAL CORPORATION (US) | 2023-08-22 | — | — | US | disclosed |
| US-11724993-B2 | Acesulfame potassium compositions and processes for producing same | CELANESE INTERNATIONAL CORPORATION (US) | 2023-08-15 | — | — | US | disclosed |
| US-11724994-B2 | Acesulfame potassium compositions and processes for producing same | CELANESE INTERNATIONAL CORPORATION (US) | 2023-08-15 | — | — | US | disclosed |
| US-11718594-B2 | Acesulfame potassium compositions and processes for producing same | CELANESE INTERNATIONAL CORPORATION (US) | 2023-08-08 | — | — | US | disclosed |
| CN-1007978-B | PROCESS FOR PREPARING OF 6-METHYL-3, 4-DIHYDRO-1,2,3-OXATHIAZIN-4-ONE 2,2-DIOXIDE AND ITS NON-TOXIC SALTS | HOECHST AG (DE) | 1990-05-16 | — | — | CN | disclosed |
| EP-0159516-B1 | METHOD FOR THE PREPARATION OF 6-METHYL-3,4-DIHYDRO-1,2,3-OXATHIAZIN-4-ONE-2,2-DIOXIDE AND ITS NON-TOXIC SALTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-01-20 | — | — | EP | disclosed |
| US-4695629-A | Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-09-22 | — | — | US | disclosed |
| US-4638063-A | Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-01-20 | — | — | US | disclosed |
| CN-85104277-A | Process for preparing 6-methyl-3, 4-dihydro-1, 2, 3-thiazin-4-one 2, 2-dioxide and its non-toxic salts, and process for preparing acetoacetamide-N-sulfonic acid | — | 1986-12-03 | — | — | CN | disclosed |
| CN-85104278-A | A kind of preparation 6-methyl-3,4-dihydro-1,2,3-thiazine-4-ketone 2, the method for 2-dioxide and nontoxicity salt thereof | — | 1986-12-03 | — | — | CN | disclosed |
| US-4607100-A | Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-08-19 | — | — | US | disclosed |
| US-4563521-A | Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-01-07 | — | — | US | disclosed |
| EP-0159516-A1 | Method for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide and its non-toxic salts | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-10-30 | — | — | EP | disclosed |
| EP-0155634-A2 | Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and of its non-toxic salts, as well as of acetoacetamide-N-sulfonic acid occurring as an intermediary in this process, and its salts | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-09-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718594-B2 | Acesulfame potassium compositions and processes for producing same | ACE, AGT, KCNJ1 | FDPS 543/4885 |
| US-11731948-B2 | Acesulfame potassium compositions and processes for producing same | AGT, ACE, HCN4 | FDPS 1333/4885 |
| US-20230322697-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | AGT, ACE, TST | FDPS 643/4885 |
| US-20230322696-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | ACE, AGT, KCNJ1 | FDPS 543/4885 |
| US-20230331687-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | ACE, AGT, TST | FDPS 797/4885 |
| US-11724994-B2 | Acesulfame potassium compositions and processes for producing same | AGT, ACE, TST | FDPS 643/4885 |
| US-20230322698-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | AGT, ACE, HCN4 | FDPS 1333/4885 |
| US-11724993-B2 | Acesulfame potassium compositions and processes for producing same | ACE, AGT, TST | FDPS 797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.